These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 30089789)
21. Simultaneous effects on parvalbumin-positive interneuron and dopaminergic system development in a transgenic rat model for sporadic schizophrenia. Hamburg H; Trossbach SV; Bader V; Chwiesko C; Kipar A; Sauvage M; Crum WR; Vernon AC; Bidmon HJ; Korth C Sci Rep; 2016 Oct; 6():34946. PubMed ID: 27721451 [TBL] [Abstract][Full Text] [Related]
22. Emerging potential of cannabidiol in reversing proteinopathies. Dash R; Ali MC; Jahan I; Munni YA; Mitra S; Hannan MA; Timalsina B; Oktaviani DF; Choi HJ; Moon IS Ageing Res Rev; 2021 Jan; 65():101209. PubMed ID: 33181336 [TBL] [Abstract][Full Text] [Related]
23. TAR DNA-Binding Protein 43 and Disrupted in Schizophrenia 1 Coaggregation Disrupts Dendritic Local Translation and Mental Function in Frontotemporal Lobar Degeneration. Endo R; Takashima N; Nekooki-Machida Y; Komi Y; Hui KK; Takao M; Akatsu H; Murayama S; Sawa A; Tanaka M Biol Psychiatry; 2018 Oct; 84(7):509-521. PubMed ID: 29752072 [TBL] [Abstract][Full Text] [Related]
24. Therapeutic Strategies to Reduce the Toxicity of Misfolded Protein Oligomers. Kreiser RP; Wright AK; Block NR; Hollows JE; Nguyen LT; LeForte K; Mannini B; Vendruscolo M; Limbocker R Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33212787 [TBL] [Abstract][Full Text] [Related]
25. Misassembly of full-length Disrupted-in-Schizophrenia 1 protein is linked to altered dopamine homeostasis and behavioral deficits. Trossbach SV; Bader V; Hecher L; Pum ME; Masoud ST; Prikulis I; Schäble S; de Souza Silva MA; Su P; Boulat B; Chwiesko C; Poschmann G; Stühler K; Lohr KM; Stout KA; Oskamp A; Godsave SF; Müller-Schiffmann A; Bilzer T; Steiner H; Peters PJ; Bauer A; Sauvage M; Ramsey AJ; Miller GW; Liu F; Seeman P; Brandon NJ; Huston JP; Korth C Mol Psychiatry; 2016 Nov; 21(11):1561-1572. PubMed ID: 26754951 [TBL] [Abstract][Full Text] [Related]
26. Proteomic analysis of protein homeostasis and aggregation. Laskowska E; Kuczyńska-Wiśnik D; Lipińska B J Proteomics; 2019 Apr; 198():98-112. PubMed ID: 30529741 [TBL] [Abstract][Full Text] [Related]
27. The pathogenic mechanism of dysbindin-1B toxic aggregation: BLOC-1 and intercellular vesicle trafficking. Yang W; Zhu C; Shen Y; Xu Q Neuroscience; 2016 Oct; 333():78-91. PubMed ID: 27421225 [TBL] [Abstract][Full Text] [Related]
29. Mechanistic Insights into the Role of Molecular Chaperones in Protein Misfolding Diseases: From Molecular Recognition to Amyloid Disassembly. Hervás R; Oroz J Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33276458 [TBL] [Abstract][Full Text] [Related]
30. Viral capsid assembly as a model for protein aggregation diseases: Active processes catalyzed by cellular assembly machines comprising novel drug targets. Marreiros R; Müller-Schiffmann A; Bader V; Selvarajah S; Dey D; Lingappa VR; Korth C Virus Res; 2015 Sep; 207():155-64. PubMed ID: 25451064 [TBL] [Abstract][Full Text] [Related]
31. Cross-seeding of misfolded proteins: implications for etiology and pathogenesis of protein misfolding diseases. Morales R; Moreno-Gonzalez I; Soto C PLoS Pathog; 2013 Sep; 9(9):e1003537. PubMed ID: 24068917 [No Abstract] [Full Text] [Related]
32. Neurodegenerative diseases linked to misfolded proteins and their therapeutic approaches: A review. Khanam H; Ali A; Asif M; Shamsuzzaman Eur J Med Chem; 2016 Nov; 124():1121-1141. PubMed ID: 27597727 [TBL] [Abstract][Full Text] [Related]
33. A quantitative model of human neurodegenerative diseases involving protein aggregation. Kepp KP Neurobiol Aging; 2019 Aug; 80():46-55. PubMed ID: 31102901 [TBL] [Abstract][Full Text] [Related]
34. A chaperome subnetwork safeguards proteostasis in aging and neurodegenerative disease. Brehme M; Voisine C; Rolland T; Wachi S; Soper JH; Zhu Y; Orton K; Villella A; Garza D; Vidal M; Ge H; Morimoto RI Cell Rep; 2014 Nov; 9(3):1135-50. PubMed ID: 25437566 [TBL] [Abstract][Full Text] [Related]
35. Differential α-synuclein expression contributes to selective vulnerability of hippocampal neuron subpopulations to fibril-induced toxicity. Luna E; Decker SC; Riddle DM; Caputo A; Zhang B; Cole T; Caswell C; Xie SX; Lee VMY; Luk KC Acta Neuropathol; 2018 Jun; 135(6):855-875. PubMed ID: 29502200 [TBL] [Abstract][Full Text] [Related]
36. Neurodegenerative disorders: dysregulation of a carefully maintained balance? Swart C; Haylett W; Kinnear C; Johnson G; Bardien S; Loos B Exp Gerontol; 2014 Oct; 58():279-91. PubMed ID: 25219768 [TBL] [Abstract][Full Text] [Related]
37. Proteostasis impairment in protein-misfolding and -aggregation diseases. Hipp MS; Park SH; Hartl FU Trends Cell Biol; 2014 Sep; 24(9):506-14. PubMed ID: 24946960 [TBL] [Abstract][Full Text] [Related]
38. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies. Ciechanover A; Kwon YT Exp Mol Med; 2015 Mar; 47(3):e147. PubMed ID: 25766616 [TBL] [Abstract][Full Text] [Related]
39. A Mutation in NPAS3 That Segregates with Schizophrenia in a Small Family Leads to Protein Aggregation. Nucifora LG; Wu YC; Lee BJ; Sha L; Margolis RL; Ross CA; Sawa A; Nucifora FC Mol Neuropsychiatry; 2016 Oct; 2(3):133-144. PubMed ID: 27867938 [TBL] [Abstract][Full Text] [Related]
40. Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain. Weickert CS; Straub RE; McClintock BW; Matsumoto M; Hashimoto R; Hyde TM; Herman MM; Weinberger DR; Kleinman JE Arch Gen Psychiatry; 2004 Jun; 61(6):544-55. PubMed ID: 15184234 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]